Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in South Carolina
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in South Carolina
| Provider | Medicare | Services |
|---|---|---|
| Laboratory Corporation Of America... | $45.28 | 187 |
| Betz, William MD | $45.42 | 81 |
| Khalil, Sara M.D. | $45.42 | 78 |
| Quest Diagnostics Clinical... | $43.12 | 38 |
South Carolina Pricing in Context
In South Carolina, CPT code G0472 (Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s)) carries an average Medicare payment of $44.93 — 0% above the national benchmark of $44.86. 37 providers across the state submitted claims for this procedure in 2023, performing 569 total services. Individual payments in SC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in South Carolina is $87.46, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because South Carolina sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Preventive Screening procedures, the estimated commercial insurance price in South Carolina lands near $105.59, with self-pay cash prices typically around $57.75. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) cost in South Carolina?
The average Medicare payment for Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in South Carolina is $44.93, which is 0% above the national average of $44.86. Providers in SC typically bill $87.46 for this procedure.
What does Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) cost with insurance in South Carolina?
With commercial insurance in South Carolina, Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) costs an estimated $105.59. Without insurance, the estimated cash price is $57.75. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in South Carolina?
37 providers in South Carolina billed Medicare for Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in 2023, performing 569 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) cheaper in South Carolina than the national average?
No — Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) costs 0% above the national average in South Carolina. The state average Medicare payment is $44.93 compared to $44.86 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.